StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

HCW Biologics's total debt was $6.56M at Jun 30, 2026. For fiscal 2025 it was $6.81M, up 7.8% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.81M+7.8%
FY2024Dec 31, 2024$6.31M+5188.8%
FY2023Dec 31, 2023$119.40K-99.7%
FY2022Dec 31, 2022$38.27M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.56M+2.2%
Q1 FY2026Mar 31, 2026$6.58M+5.5%
Q4 FY2025Dec 31, 2025$6.81M+7.8%
Q3 FY2025Sep 30, 2025$6.81M+7.4%
Q2 FY2025Jun 30, 2025$6.42M+5278.0%
Q1 FY2025Mar 31, 2025$6.23M+5197.7%
Q4 FY2024Dec 31, 2024$6.31M+6403.2%
Q3 FY2024Sep 30, 2024$6.34M+9227.2%
Q4 FY2023Dec 31, 2023$119.40K-99.7%
Q3 FY2023Sep 30, 2023$117.68K–
Q2 FY2023Jun 30, 2023$97.10K–
Q1 FY2023Mar 31, 2023$67.98K–
Q4 FY2022Dec 31, 2022$38.27M–

More HCW Biologics figures

See a number that looks wrong?